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SHORT COMMUNICATION
Topoisomerase inhibitors suppressed lithocholic acid-induced promotion
of transformation in BALB/3T3
M. Kaneko & J. Horikoshi
Biophysics Division, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.
Epidemiological studies have suggested that a high fat diet
and the metabolic activity of gut flora are major factors
contributing to development of colon cancer (Reddy, 1981).
Studies in rats have showed that bile acids such as
deoxycholic acid and lithocholic acid enhance tumour
formation in the colon (Reddy, 1981), stomach (Kobori et
al., 1984) and liver (Cameron et al., 1981). Moreover, bile
acids have been found to have initiating (Kelsey et al., 1979)
or enhancing (Kaibara et al., 1984) effects in transformation
of cultured cells. We have been attempting to clarify the
mechanism of these biological effects by studying DNA
lesions in cultured cells exposed to bile acids. Previously, we
found that various bile acids induced DNA single strand
breaks, the extent of which depended on their degree of
incorporation into cultured cells, and that most of the single
strand breaks (up to 80%) were associated with protein-
DNA cross linking. We also found that the induction of
single strand breaks was effectively suppressed by topo-
isomerase inhibitors such as novobiocin (Nov), nalidixic acid
(Nal), oxolinic acid (Oxl) and coumermycin A (Kaneko et
al., 1986). To examine whether these inhibitors also inhibited
cell transformation, we investigated their effects on
promotion of transformation by lithocholic acid (LC) in
Balb/3T3 cells. Here we show that Nal and Oxl efficiently
reduced the promotion of transformation by LC initiated by
3-methylcholanthrene (MC) in BALB/3T3 fibroblasts.
The BALB/3T3, A31-1-1 in vitro transformation system was
used. This system has been well characterized (Kakunga,
1973) and used as a model system in two-step carcinogenesis
experiments (Kennedy & Little, 1978). The cells were grown
in Eagle's minimum essential medium supplemented with
10% heat-inactivated foetal calf serum. For transformation,
inocula of 1 x 104 cells of the A31-1-1 BALB/3T3 cell line
(passage 3 after receipt as a gift from Dr T. Kuroki) were
seeded into ten 60mm cell culture dishes per experimental
group. After 24h, the cultures were treated with MC
(Spectrum Chem, MFG. Corp., Redondo Beach, Ca.) for
72h at 37°C. Then the medium was changed, and culture
was continued for 4 weeks in the presence or absence of LC
(Sigma Chem. Co., St Louis, Mo.) with or without Oxl or
Nal (Sigma Chem. Co.) as indicated. The medium was
renewed twice a week. Type III foci (Reznikoff et al., 1973)
in each plate were scored as transformants with the aid of a
dissecting microscope. The criteria adopted for them are that
cells are highly condensed, heavily piled upon one another,
and randomly oriented. In addition, areas of patchy, dense
growth without criss-crossing were often observed but they
were clearly distinct from the above foci and were not
scored. MC and LC were dissolved in dimethylsulfoxide
(Pierce, Rockfield, Il.). Nal and Nov were dissolved in
distilled water and OxI was dissolved in 40mm NaOH. The
promoter and inhibitors were present throughout the
expression period after the treatment with MC. Four dishes
per group seeded with 200 cells were treated in parallel to
assess the effects of the various treatments upon colony
forming efficiency. Colonies in test dishes were scored after
incubation for one week.
Five experiments were carried out to determine the effects
of Nal and Oxl on MC-induced transformation and LC-
induced promotion of transformation, together with
confirmation of LC-induced promotion (Kaibara et al.,
1984) and three of these experiments (A, B and C) are shown
in Table I. As shown in expts. A, B and C, Oxl and Nal
clearly suppressed transformation promoted by LC.
Surprisingly, the suppression was frequently to below the
level of transformation induced by MC only. In most
experiments, these inhibitors also suppressed transformation
induced by MC only. On the other hand, novobiocin, which
also suppressed induction of DNA strand breaks by LC,
little affected LC-induced promotion of transformation when
added at 75pm, which was the highest concentration possible
because of its high toxicity (Table II). LC alone (40 M)
induced transformation on prolonged treatment (expts. A, B
and C), but not on a single treatment (data not shown).
Therefore, it may have weak initiating activity in BALB/3T3
cells, as it does in hamster embryo cells (Kelsey et al., 1979).
The transformation induced by prolonged treatment with LC
was also suppressed by Nal (expt. C) or Oxl (expt. B). Thus,
the prokaryotic topoisomerase inhibitors Nal and Oxl, but
not Nov, suppressed transformation induced by MC or LC;
and also promotion by LC after initiation by MC in
BALB/3T3 cells as well as suppressing LC-induced DNA
strand breaks in cultured human fibroblasts (Kaneko et al.,
1986).
Neither the way in which LC acts on inducing DNA
strand breaks and transformation nor the way in which Oxl
and Nal act on suppressing them are known. The following
observations suggest that topoisomerase participate in these
processes: First, Oxl, Nal and Nov have been reported to
inhibit 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-
AMSA) induced DNA-protein cross linking mediated by
topoisomerase II (Pommier et al., 1984, Nelson et al., 1984).
Moreover, we found previously that they also inhibited
DNA-protein cross linking induced by LC in cultured
fibroblasts (Kaneko et al., 1986). Second, in a preliminary
experiment we found that in a cell free system LC inhibited
topoisomerase assayed by measuring relaxation of closed
circular DNA (unpublished data). Nal may inhibit LC-
induced processes by reducing the level of ATP, since it was
found to interfere with oxidative phosphorylation in isolated
rat liver mitochondria and to inhibit ATP synthesis
(Gallagher et al., 1986). However, its effect may not be
mediated by decrease in the ATP level, because DNA strand
breaks in cultured fibroblasts were increased 2- to 3-fold in
the presence of an uncoupler such as oligomycin or
dinitrophenol (unpublished results). In addition, it was
shown that Nal and Oxl inhibit topoisomerase II in a cell
free system from HeLa cells at high concentration (Miller et
al., 1981) but that Nal does not inhibit topoisomerase from
D. melanogaster (Hsie & Brutlag, 1980). Based on these
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Table I Effects of oxolinic acid and nalidixic acid on lithocholic acid-induced promotion of
transformation initiated by 3-methylcholanthrene
Treatment No. of Fractions
Plating type III ofdishes Frequency of
Expt. Initiation Promotiona efficiencyb focildishb withoutfoci transformation
/200 /10 xl0-4
A. None None 104.0+ 8.8 0.0 10 0.0
LC 96.5+ 9.2 0.4+1.0 8 0.86+ 2.10
Oxl 110.3+ 9.5 0.0 10 0.0
LC+Oxl 98.2+ 6.8 0.4+0.5 6 0.84+ 1.10
MC(1pugml 1) None 76.8+ 3.0 0.8+0.8 4 2.16+ 2.14
LC 76.0+13.1 7.3+1.8 0 19.98+ 4.92c
Oxl 76.5+ 7.3 0.3+0.5 7 0.82+ 1.30
LC+Oxl 68.7+ 7.4 0.8+0.7 3 2.36+ 2.02d
B. None None 113.5 + 8.9 0.0 10 0.0
LC 107.8+ 6.8 0.6+0.8 6 1.1 + 1.6
LC+Oxl 110.3+ 8.1 0.1+0.3 9 0.2 + 0.6
MC(1pgml 1) None 62.8+ 8.5 2.6+2.0 4 8.3 + 6.4
LC 65.8 + 3.5 5.9+3.3 0 17.9 +10.0
Oxl 70.0+ 5.4 0.7+0.8 5 2.0 + 2.3e
LC+Oxl 69.0+ 1.6 1.7+1.4 3 4.9 + 4.1d
C. None None 77.0+ 5.9 0.0 10 0.0
LC 69.8+ 3.3 1.5+1.2 2 4.3 + 3.4
Nal 81.0+ 5.0 0.0 10 0.0
LC+Nal 68.3+ 9.3 0.1 +0.3 9 0.3 + 0.9
MC(1ugml-) None 28.8+ 5.0 0.9+2.7 9 6.3 +18.9
LC 24.8+ 3.0 8.1+2.6 0 65.3 +21.0c
LC+Nal 51.0+10.0 0.3+0.6 8 1.2 + 2.4d
MC(5jigml1) None 30.0+ 8.1 2.9+1.8 0 19.3 +12.0
LC 27.0+ 1.9 18.2+6.7 0 134.8 +49.6f
Nal 19.8+ 3.7 0.6+0.9 9 6.1 + 9.29
LC+Nal 45.8 + 7.0 0.1+0.3 6 0.4 + 1.2h
aConcentrations used were as follows: LC, 40,uM; Oxl, 100pM; Nal, 0.5mM; bValues are means+s.d.
for 4 dishes (plating efficiency) or 10 dishes (transformation); cDiffers from MC(I pgml-1) (P<0.001
for expt. A, P<0.001 for expt. C) by t-test; dDiffers from MC(I pgml-1) plus LC (P<0.001 for both
expt. A and C and P<0.01 for expt. B); eDiffers from MC(1 pgml-1) (P<0.01); 'Differs from
MS(5pgml-1) (P<0.001); gDiffers from MC(5 ugml-1) (P<0.02); hDiffers from MC(S5gml-1) plus
LC (P<0.001).
Table II Effects of novobiocin on lithocholic acid-induced promotion of transformation
initiated by 3-methylcholanthrene
Treatment No. of Fractions
Plating type III ofdishes Frequency of
Initiation Promotiona efficiencyb foci/dishb withoutfoci transformation
/200 /10 xl0-4
None None 107.5+ 9.4 0.0 10 0.0
LC 101.3+ 5.4 2.7+ 1.7 0 5.3+ 3.4
Nov 97.8+ 2.5 0.0 10 0.0
LC+Nov 100.8+10.0 4.8+7.5 0 9.5+ 14.9
MC(lpgml 1) None 73.5+ 6.9 1.0+1.3 5 2.7+ 3.5
LC 74.5+ 4.3 20.1+3.9 0 54.0+10.5
Nov 71.3+10.2 4.4+2.3 1 12.3+28.6
LC+Nov 62.3+ 4.5 17.2+6.7 0 55.2+21.5
aConcentration used were: LC, 40pM; Nov, 75pM; bAs foot-note to Table I.
findings we propose that LC, Oxl and Nal may act in the
following way on the induction of DNA strand breaks and
transformation and on their suppression: First, LC might
interfere with some function of topoisomerase and this
interference might induce DNA-protein cross linking.
Second, LC-induced DNA-protein cross linking might play a
role in LC-induced promotion of transformation. Third, the
interaction between LC and topoisomerases might be
inhibited directly or indirectly by Oxl or Nal, or cells treated
with Oxl or Nal might be able to repair LC-induced damage.
Experiments using a cell-free system are necessary to
investigate these possibilities and will help in determining
whether topoisomerases actually participate in transformation
induced by MC alone.
Recently, there has been increasing interest in the function
ot topoisomerases. There are suggestions (Wang, 1985) that
topoisomerase I is essential for RNA transcription and that
topoisomerase II is essential to DNA replication. Also, it is
reported that topoisomerase II is a major constituent of
nuclear scaffold (Earnshaw et al., 1985) and is essential to
mitosis (Holm et al., 1985). Modification of topoisomerase II
by an antineoplastic agent such as m-AMSA was reported to
induce preferential cleavage at a DNase I hypersensitive
region (- 270bp upstream of Ori) of SV40 chromatin in616 M. KANEKO & J. HORIKOSHI
monkey kidney cells (Yang et al., 1985) and sister chromatid
exchange in Chinese hamster cells (Dillehay et al., 1987). On
the other hand, recently, the effect of 4#-phorbol 12,13-
dibutyrate on differentiation of HL-60 cells was found to be
suppressed by inhibitors of topoisomerase II such as Nov
and m-AMSA and activation of topoisomerase II due to
phosphorylation by protein kinase C was suggested to be
involved in the differentiation process (Sahyoun et al., 1986).
Thus, topoisomerases are considered to be important not
only in differentiation but also in carcinogenesis after
activation or inactivation. But there have been no previous
suggestions that topoisomerases participate in promotion of
carcinogenesis or in the whole process of carcinogenesis.
Therefore, it is important to examine whether they are
essential for induction of transformation by MC and
induction of promotion by LC.
We are grateful to Dr T. Kuroki, University of Tokyo, Medical
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Kodama and T. Kimura, of this division, for valuable discussions.
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